APA

Kato J., Mori T., Yokoyama K., Tsukada Y., Ueda T., Shimizu T. & Okamoto S. (20111212). Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma. : Bone marrow transplantation.

Chicago

Kato J, Mori T, Yokoyama K, Tsukada Y, Ueda T, Shimizu T and Okamoto S. 20111212. Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma. : Bone marrow transplantation.

Harvard

Kato J., Mori T., Yokoyama K., Tsukada Y., Ueda T., Shimizu T. and Okamoto S. (20111212). Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma. : Bone marrow transplantation.

MLA

Kato J, Mori T, Yokoyama K, Tsukada Y, Ueda T, Shimizu T and Okamoto S. Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma. : Bone marrow transplantation. 20111212.